In another study, the consequential reduction in NSB1 expression following PARP5B inhibition was associated with the activation of ATR signaling, which in turn led to senescence and apoptosis, highlighting PARP5B as a potential target for chemotherapeutic intervention in HNSCC [169]. The gene discussed is TNKS2; the disease is head and neck squamous cell carcinoma.